News
Minnesota companies on pace for record year in acquisition deals
Summary by The Minneapolis Editorial Desk Star Tribune
· August 28, 2026
· 1 min read
Photo: Star Tribune · view original
Story provenance No corrections
Summary created by The Minneapolis Editorial Desk — automated, rule-governed Published by Star Tribune Original story Read at the source Source published Aug 28, 2026 Indexed here Aug 28, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points A notable deal is Bio-Techne's acquisition by Merck, valued at $11. The Bio-Techne and Merck deal is a highlight of the activity in the state.
Companies based in Minnesota are seeing a significant amount of acquisition activity. A notable deal is Bio-Techne's acquisition by Merck, valued at $11.3 billion. This transaction is part of a larger global trend of mega-deals.
The Bio-Techne and Merck deal is a highlight of the activity in the state. It contributes to a year that is on pace to be a record for acquisition deals in Minnesota.
Further details about the acquisition activity and its implications are available from the source. The surge in large deals is a notable development in the business world.
More News Today’s briefing Local events
Why this story is here
Star Tribune reported and published this story. The Minneapolis selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by Star Tribune . The Minneapolis selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Star Tribune . Have a tip or correction? Contact the editor .
Category: News Published: August 28, 2026 Source: Star Tribune Reading time: 1 min
Frequently asked about this story
What is this story about? Companies based in Minnesota are seeing a significant amount of acquisition activity. A notable deal is Bio-Techne's acquisition by Merck, valued at $11.3 billion. This transaction is part of a…
When was this published? This article was first published on August 28, 2026 by Star Tribune and curated for The Minneapolis readers.
Who reported this story? This story was reported by Star Tribune. To learn more about how The Minneapolis selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Minneapolis, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
